Valeo Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.35M | Buy |
2,690
+34
| +1% | +$16.3K | 0.03% | 257 |
|
|
2026
Q1 | $1.31M | Sell |
2,656
-2,026
| -43% | -$1.1M | 0.03% | 225 |
|
|
2025
Q4 | $2.71M | Buy |
4,682
+116
| +3% | +$65.6K | 0.06% | 145 |
|
|
2025
Q3 | $2.21M | Buy |
4,566
+2,036
| +80% | +$948K | 0.05% | 154 |
|
|
2025
Q2 | $1.03M | Sell |
2,530
-1,698
| -40% | -$710K | 0.03% | 295 |
|
|
2025
Q1 | $2.1M | Sell |
4,228
-34
| -0.8% | -$18.4K | 0.06% | 151 |
|
|
2024
Q4 | $2.22M | Sell |
4,262
-86
| -2% | -$47.3K | 0.06% | 140 |
|
|
2024
Q3 | $2.69M | Buy |
4,348
+198
| +5% | +$117K | 0.08% | 125 |
|
|
2024
Q2 | $2.3M | Buy |
4,150
+111
| +3% | +$63.6K | 0.07% | 129 |
|
|
2024
Q1 | $2.33M | Buy |
4,039
+255
| +7% | +$143K | 0.08% | 129 |
|
|
2023
Q4 | $2.01M | Buy |
3,784
+385
| +11% | +$186K | 0.08% | 136 |
|
|
2023
Q3 | $1.72M | Buy |
3,399
+214
| +7% | +$114K | 0.08% | 145 |
|
|
2023
Q2 | $1.66M | Sell |
3,185
-515
| -14% | -$278K | 0.08% | 142 |
|
|
2023
Q1 | $2.13M | Buy |
3,700
+1,012
| +38% | +$570K | 0.1% | 118 |
|
|
2022
Q4 | $1.48M | Buy |
2,688
+343
| +15% | +$182K | 0.08% | 145 |
|
|
2022
Q3 | $1.19M | Buy |
2,345
+578
| +33% | +$323K | 0.08% | 153 |
|
|
2022
Q2 | $958K | Sell |
1,767
-1,049
| -37% | -$577K | 0.06% | 168 |
|
|
2022
Q1 | $1.66M | Buy |
2,816
+767
| +37% | +$441K | 0.08% | 137 |
|
|
2021
Q4 | $1.37M | Sell |
2,049
-3
| -0.1% | -$1.87K | 0.07% | 147 |
|
|
2021
Q3 | $1.17M | Buy |
2,052
+685
| +50% | +$376K | 0.07% | 164 |
|
|
2021
Q2 | $690K | Buy |
1,367
+50
| +4% | +$23.6K | 0.04% | 209 |
|
|
2021
Q1 | $601K | Buy |
1,317
+207
| +19% | +$98.8K | 0.03% | 249 |
|
|
2020
Q4 | $517K | Buy |
1,110
+34
| +3% | +$15.9K | 0.03% | 241 |
|
|
2020
Q3 | $475K | Sell |
1,076
-573
| -35% | -$237K | 0.04% | 196 |
|
|
2020
Q2 | $597K | Buy |
1,649
+130
| +9% | +$43.6K | 0.05% | 170 |
|
|
2020
Q1 | $478K | Sell |
1,519
-244
| -14% | -$76.9K | 0.05% | 174 |
|
|
2019
Q4 | $573K | Buy |
1,763
+200
| +13% | +$60.6K | 0.06% | 177 |
|
|
2019
Q3 | $455K | Buy |
1,563
+8
| +0.5% | +$2.29K | 0.05% | 181 |
|
|
2019
Q2 | $457K | Sell |
1,555
-356
| -19% | -$98.1K | 0.05% | 186 |
|
|
2019
Q1 | $523K | Buy |
1,911
+38
| +2% | +$9.46K | 0.06% | 173 |
|
|
2018
Q4 | $419K | Sell |
1,873
-19
| -1% | -$4.46K | 0.06% | 179 |
|
|
2018
Q3 | $442K | Buy |
1,892
+25
| +1% | +$5.75K | 0.06% | 184 |
|
|
2018
Q2 | $431K | Buy |
1,867
+158
| +9% | +$33.5K | 0.06% | 185 |
|
|
2018
Q1 | $353K | Sell |
1,709
-500
| -23% | -$105K | 0.06% | 190 |
|
|
2017
Q4 | $419K | Buy |
2,209
+2,176
| +6,594% | +$417K | 0.07% | 167 |
|
|
2017
Q3 | $6K | Buy |
+33
| New | +$5.98K | ﹤0.01% | 844 |
|
Other funds holding TMO
Valeo Financial Advisors's TMO Position: Q2 2026 in Review
Valeo Financial Advisors increased its Thermo Fisher Scientific (TMO) stake by 1.3% in Q2 2026, buying an estimated $16.3K and bringing the position to 2,690 shares worth $1.35M. The position accounts for 0.03% of the portfolio, ranked #257.
Valeo Financial Advisors first reported a position in TMO in Q3 2017 and has held it in 36 quarters since. The position peaked at $2.71M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Valeo Financial Advisors held 2,690 shares of Thermo Fisher Scientific worth $1.35M as of Q2 2026.
- Valeo Financial Advisors bought 34 Thermo Fisher Scientific shares in Q2 2026, an estimated $16.3K.
- Thermo Fisher Scientific made up 0.03% of Valeo Financial Advisors's portfolio in Q2 2026, its #257 holding.
- Valeo Financial Advisors first reported a position in Thermo Fisher Scientific in Q3 2017 and has held it in 36 quarters since.
- Valeo Financial Advisors's Thermo Fisher Scientific position peaked at $2.71M in Q4 2025.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Valeo Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.